1. Introduction {#sec1}
===============

Asthma is a chronic condition with an estimated 358.2 million sufferers worldwide \[[@bib1]\].

More than 20% of adolescents aged 10--14 years were diagnosed with asthma in North America, United Kingdom, and Australia, and those in this age group have more mortality or disability than other age groups in Taiwan \[[@bib1],[@bib2]\]. The biological, psychological, and socio-emotional changes adolescents are undergoing during their development have considerable impact on asthma management for this group \[[@bib3],[@bib4]\]. Adolescents with chronic diseases are reported to have a high frequency of non-adherence to treatment regimens \[[@bib5]\]. Similar findings with an increased trend in asthma cases and intension non-adherence for Taiwanese adolescents have been experienced \[[@bib2]\]. According to the National Health Insurance Research Database in Taiwan in 2017, the prevalence of adolescents with asthma continues to increase (from 12.99% to 22.02%) \[[@bib6]\]. Many adolescents take no actions when experiencing asthma attacks \[[@bib7]\], resulting in poor asthma outcomes \[[@bib8],[@bib9]\].

Evidence showed that self-management programs guided by a theoretical framework provide solid basis and lead to effective outcomes \[[@bib10]\]. Bandura\'s self-efficacy model includes efficacy-expectation (performance accomplishment, vicarious experience, verbal persuasion, and physiological information) and outcome-expectation (what outcome people expect from engaging in a particular behaviour) \[[@bib11]\]. Studies show adolescents with high levels of self-efficacy were able to manage their asthmatic symptoms, and have improved health outcomes \[[@bib12],[@bib13]\]. Asthma self-management programs (ASMPs) based on the self-efficacy model have been widely used \[[@bib14]\], however, there was no theoretical based intervention study found in Taiwan, and limited rigorous research design to determine the effectiveness of the intervention was found \[[@bib14], [@bib15], [@bib16], [@bib17]\].

Furthermore, improving the effectiveness of asthma self-management programs for adolescents is imperative not only providing them with knowledge, but also considering their physical and psychosocial developmental stages \[[@bib18]\]. For example, adolescents with asthma may tend to make themselves unattached to their asthma symptoms; they thought these could be a normal phenomenon or progression, and the symptom would disappear naturally, without realising the symptoms would be a serious asthma exacerbation \[[@bib19]\]. Many adolescents did not use medications while the symptoms occurred due to the embarrassment of taking medications in front of their friends \[[@bib19]\]. Some adolescents may feel that their parent or teacher does not care much about their asthma conditions, as they continue to be surrounded by parent\'s persistent smoking, and/or teachers\' disapprovals for stopping physical activities expected to trigger an asthma exacerbation \[[@bib20]\]. Thus, special developmental considerations should be made. This highlights an urgent need to effectively address asthma management.

1.1. Aim {#sec1.1}
--------

This study aimed to develop and evaluate efficacy of the asthma self-management program (ASMP) for adolescents in Taiwan.

2. Methods {#sec2}
==========

2.1. Designs {#sec2.1}
------------

A two-arm, parallel-group, randomized controlled trial was used. This study was conducted in a more than 1000-bed tertiary hospital located in northern Taiwan. Inclusion criteria included being diagnosed with asthma and receiving treatment, 12--18 years old, able to converse in Chinese, with access to a mobile phone. Patients diagnosed with a cognitive deficiency were excluded. The primary outcome was asthma self-efficacy and secondary outcomes were outcome-expectancy, asthma prevention and management behaviours, and asthma symptoms.

2.2. Sample size {#sec2.2}
----------------

A smaller sample of 90 participants with an attrition rate of 7.8% to reach the medium effect size than initially estimated in our protocol paper \[[@bib21]\] were recruited. The sample size calculation was based on the main outcome of self-efficacy scores between groups at a 0.05 significance level of a power .8 and a 0.58 effect size \[[@bib22]\].

2.3. Randomization {#sec2.3}
------------------

As outlined in our protocol paper \[[@bib21]\], randomization was undertaken using a computer-generated random number by an independent statistician. Participants were allocated to the intervention or control group in a one-to-one ratio.

2.4. Intervention {#sec2.4}
-----------------

Participants in the experimental group received the ASMP in addition to the usual care. The usual care consisted of standard asthma care information based on the Taiwan National Health Insurance Institute Administration Ministry of Health and Welfare guidelines, including information for improving symptoms management, such as asthma medications, monitoring and symptoms management \[[@bib23]\], and it was provided by a registered nurse in the outpatient clinics.

The ASMP for Taiwanese adolescents was developed based on Bandura\'s self-efficacy model \[[@bib11]\]. The content of the ASMP as described in our protocol paper \[[@bib21]\] was developed using the guideline consisted of environmental factors and comorbid conditions that affect asthma, education for a partnership in care, medication, assessing and monitoring asthma severity and asthma control. Validity of the ASMP contents in Chinese was determined by a panel of experts who reached 100% agreements \[[@bib24]\].

The modes of delivery were adapted from a multi-components of self-management program for patients with chronic diseases \[[@bib25]\]. The ASMP contained three face-to-face sessions, followed by two short text messages and a telephone call. A booklet titled "Living with Asthma Together" including "My Asthma Action Plan" was provided at the first face-to-face meeting for recording participants' goals for asthma management in week 1, discussing their feeling and concerns about asthma symptoms. Week 2, in a face-to-face meeting. At week 3, the ASMP session was focused on problem solving skills of asthma exacerbation. Two text messages were sent weekly after each meeting for 4 weeks as reminders to encourage participants to carry out their self-management behaviours. A telephone call was made at week 4 to inquire how the participant was progressing. An example of applying the self-efficacy model and the contents of the ASMP is presented in [Fig. 1](#fig1){ref-type="fig"}.Fig. 1Application of a self-efficacy model for the ASMP.Fig. 1

2.5. Data collection {#sec2.5}
--------------------

The outcome measures of self-efficacy, outcome-expectancy, prevention and management behaviours, as well as the symptoms of asthma were collected at T1 (baseline) and T2 (week 4). The procedure of data collection was presented in our protocol paper \[[@bib21]\]. Data collection was undertaken by a trained research assistant who was blinded to group allocation during February to August 2014 (See [Fig. 2](#fig2){ref-type="fig"}).Fig. 2Flow diagram of the Asthma Self-Management Program Trial.Fig. 2

2.6. Measurements {#sec2.6}
-----------------

The outcomes of asthma self-efficacy, outcome-expectancy, asthma prevention and management behaviours, and controlling asthma symptoms were measured by Asthma Self-Efficacy Index \[[@bib26]\], Outcome-expectancy \[[@bib27]\], Asthma Prevention and Management Index \[[@bib26]\] and Asthma Control Test (ACT) \[[@bib28]\].

The original instruments for Asthma Self-Efficacy Index, Outcome-expectancy, and Asthma Prevention and Management Index were only available in English versions. With permissions obtained, translating these English versions into Chinese by translation and back-translation process \[[@bib29]\]. The Cronbach\'s alphas to support the reliabilities of the Chinese versions are in [Table 1](#tbl1){ref-type="table"}.Table 1Outcome measures.Table 1OutcomeScaleItemsCronbach\'s AlphaEnglish visionChinese versionAsthma self-efficacyAsthma Self-Efficacy Index14 items (1--10)0.840.83Outcome-expectancyOutcome expectancy8 items (1--10)0.840.88Asthma prevention behaviours (prevention and management)Asthma prevention and management index - *Preventive behaviors*11 items (0--3)0.710.73Asthma prevention and management index - *Management behaviors*9 items (0--3)0.530.67Asthma symptomsAsthma Control Test (ACT)5 items (1--5)0.75-0.850.84

The Asthma Management Self-Efficacy index \[[@bib26]\] was used to evaluate adolescents\' self-efficacy levels in preventing and managing asthma attacks for adolescents with asthma. Participants judge their confidence to carry out 14 actions for managing their asthma. Score of each item ranged from 1 (low self-efficacy) to 10 (high self-efficacy). Cronbach\'s alpha for this scale in Chinese version was 0.83 (See [Table 1](#tbl1){ref-type="table"}).

Outcome-expectancy \[[@bib27]\] measured the outcome expectancy of adolescents with asthma if they were compliant with related-health behaviours and asthma treatments. Expectancy scale comprised a total of 8 items. Score of each item ranged from 1 (low outcome-expectancy) to 10 (high outcome-expectancy). The Cronbach\'s alpha for this scale in Chinese version was 0.88 (See [Table 1](#tbl1){ref-type="table"}).

Asthma Prevention and Management Index \[[@bib26]\] included asthma prevention and management behaviours. The prevention behaviours measured how many behaviours and how regularly participants are undertaken in order to prevent symptoms of asthma occurring. The asthma management behaviors measured how many step participants performed to deal an asthma attack. The Prevention Index consisted of 11 items ranged from 0 to 3 for each item. The high score (3) indicated high level of asthma preventative behaviour. The Cronbach\'s alpha for this scale in Chinese version was 0.73. The 9-item Asthma Management Index ranged from 0 to 3 for each item. The high score (3) represented excellent asthma attack management. The Cronbach\'s alpha for this scale in Chinese version was 0.67.

The Asthma Control Test (ACT) \[[@bib28]\] assessed outcomes of asthmatic symptoms. The response of each item ranged from 1 to 5, The high score (5) indicated asthma symptoms were well-controlled. Permission to use available Chinese version of the ACT has been obtained from the Quality Metrics.

Participants\' severity levels of asthma at baseline were determined by the Seattle Asthma Severity and Control Questionnaire (SASCQ) which was developed by Hallstrand et al. \[[@bib30]\]. Contents of the questionnaire included symptoms of asthma at nighttime and daytime, activity limitation, exacerbation, and frequency of bronchodilators usage. The validity of this tool included criterion and construction validation. The asthma severity was defined by the highest steps of asthma severity that was obvious on any items of the SASCQ. Cronbach\'s alphas of the SASCQ in Chinese version was 0.84.

2.7. Data analysis {#sec2.7}
------------------

The homogeneity of demographic and outcomes variables were examined for the similarities (*p* \> .05) of participants' characterises and outcomes in both groups prior to undertaking data analyses \[[@bib31]\]. Data were analysed using SPSS version 21. Chi-square test was used to determine differences between groups for demographic categorical variables of sex, family smoking experience, and asthma severity levels by Seattle Asthma Severity and Control Questionnaire \[[@bib32]\], whereas independent *t*-test was used for age and years of asthma between groups. The mean differences of self-efficacy and prevention and management behaviour were examined by *t*-test; Mann-Whitney *U* test was applied for outcome-expectancy and asthma control test because of non-normal distribution. The level of significance was set at *p* \< .05.

3. Ethical approvals {#sec3}
====================

The study was approved by the participating hospital Institutional Review Boards (CGMFIRB No102-3787B) and university Human Research Ethics Committee (Ethics No140000006). Informed consents were obtained from adolescents and their parents/guardians. The researcher explained the purpose of the study; what they did during the study; what their rights, benefits, and risks participation this study to adolescents and their parents separately. If adolescents and their parents agreed to participate this study, they were asked to provide written assent and consents. Participants were also ensured their participation was voluntary. All data were saved on the university secured drive and limited access permitted to only authorised researchers to ensure the privacy and confidentiality of data.

4. Results {#sec4}
==========

4.1. Sample characteristics {#sec4.1}
---------------------------

A total of 90 patients were recruited and randomized (see [Fig. 2](#fig2){ref-type="fig"}), seven of them withdrew from this study due to a busy school schedule. There were no statistical differences in age, gender, family smoking, severity of asthma and outcome variables between completed and discontinued participants. The remaining 83 participants were randomly allocated to experimental (n = 40) and control (n = 43) groups.

The mean age was 14.2 years (*SD* = 1.8), majority of the participants were males (n = 47). Most of adolescents had a mild to intermittent level of asthma severity (n = 61). All the participants denied smoking, but nearly half of their parents were non-smokers. ([Table 2](#tbl2){ref-type="table"}).Table 2Participants' demographic characteristics.Table 2GroupsControl (n = 43)Experimental (n = 40)M (SD)M (SD)*t*-test(P)**Age**14.1 (1.9)14.5 (1.8)−1.14 (.26)^NS^**Years of Asthma**6.0 (3.7)8.31 (6.2)−0.21 (.83) ^NS^**Number (%)Number (%)χ**^**2**^**(*p)*Gender**1.4 (.24) ^NS^Male27 (62.8)20 (50.)Female16 (37.2)20 (50)**Family members smoking**3.5 (.19) ^NS^Both parents non-smokers22 (51.2)19 (47.5)Father smoking17 (39.5)13 (32.5)Mother smoking01 (2.5)Both parents smoking1 (2.3)4 (10)Other family members3 (7)3 (7.5)**Severity of asthma**1.7 (.6) ^NS^Intermittent mild30 (69.8)31 (77.5)Persistent mild8 (18.7)4 (10)Moderate4 (9.3)3 (7.5)Severe1 (2.3)2 (5.0)[^1]

4.2. Asthma self-efficacy {#sec4.2}
-------------------------

The mean asthma self-efficacy at T2 for the experimental group was 109.8 points (SD = 22.6), while the mean was 91.7 (SD = 26.6) for the control group. There were differences 18.6 points (SD = 20.2) from T2 to T1 for the experimental group. Although the mean asthma self-efficacy at T2 for the control group also increased from T1, it was to a lesser extent of 6.7 points (SD = 19.2). An independent *t*-test indicated there was a significant difference between the two groups for the change from T1 to T2 self-efficacy mean level, *t* (81) = −2.8, *p* \< .05. This finding indicated that participants in the experimental group had significant improvement in asthma self-efficacy (see [Table 3](#tbl3){ref-type="table"}).Table 3Comparison of T1 and T2 differences in self-efficacy, prevention and management behaviors for two groups (n = 83).Table 3GroupsMean difference (95% CI)*t*-testExperimentalControlT1T2T1T2*MMMM(SD)(SD)(SD)(SD)*Self-efficacy[b](#tbl3fnb){ref-type="table-fn"}91.3 (21.8)109.8 (22.6)85.1 (22.7)91.7 (26.6)−11.9 (−20.5, −3.3)−2.8[a](#tbl3fna){ref-type="table-fn"}Prevention behaviors [c](#tbl3fnc){ref-type="table-fn"}20.7 (5.0)24.6 (4.7)20.6 (5.5)21.3 (5.0)−3.2 (−1.4, −5.0)−3.5[a](#tbl3fna){ref-type="table-fn"}Management behaviors [d](#tbl3fnd){ref-type="table-fn"}17.4 (4.5)19.9 (4.6)17.9 (3.9)17.8 (4.8)−2.7 (−4.3, −1.0)−3.2[a](#tbl3fna){ref-type="table-fn"}[^2][^3][^4][^5]

4.3. Outcome-expectancy {#sec4.3}
-----------------------

The median outcome-expectancy scores for the control group at T2 was 61 (minimum = 14, maximum = 80), however, the median outcome-expectancy score for the experimental group was 70 (range from 46 to 80). Mann-Whitney *U* test indicated that there was a significant difference between the two groups regarding the change in outcome-expectancy scores, *U* = 646, Z = −2.0, *p* \< .05, The improvements in outcome-expectancy was greater for the experimental group than for the control group (see [Table 4](#tbl4){ref-type="table"}).Table 4Comparison of T1 and T2 differences in outcome-expectancy and asthma symptoms for two groups (n = 83).Table 4GroupsMann-Whitney *U*VariablesExperimentalControlT1 *Median (min-max.)*T2 Median (min-max)T1 *Median (min-max)*T2 *Median (min-max)*Outcome-expectancy [b](#tbl4fnb){ref-type="table-fn"}64 (21--80)70 (46--80)63 (9--80)61 (14--80)646[a](#tbl4fna){ref-type="table-fn"}Asthma Symptoms[c](#tbl4fnc){ref-type="table-fn"}22 (8--25)23 (15--25)22 (12--25)23 (14--25)716[^6][^7][^8]

4.4. Asthma prevention and management behaviors {#sec4.4}
-----------------------------------------------

The scores of the asthma preventive behaviour for the experimental group was 24.6 (SD = 4.7) at T2. There increased 3.9 point (*SD* = 4.6) from T1 to T2. The mean of preventive behaviour for the control group was 21.3 (SD = 5.0) at T2. There also increased but only by 0.7 points (*SD* = 3.7) from T1 to T2. Results of the statistical analysis revealed there was a significant difference between the two groups for the change from T1 to T2 preventive behaviour mean score, *t* (81) = −3.5, *p* \< .05. Adolescents with asthma who received the asthma self-management program performed more asthma preventive behaviours in order to control their asthma symptoms compared to adolescents with asthma who received the usual asthma care.

The mean of asthma management behaviour for the experimental group at T2 was 19.9 (*SD* = 4.6), while the mean of management behaviour for the control group was 17.8 (*SD* = 4.8). The mean asthma management behaviour score for the experimental group had increased by 2.6 points (*SD* = 4.0) from T1 to T2, but the mean asthma management behaviour score for the control group had dropped by 0.1 points (*SD* = 3.7). The change in management behaviours was significantly greater for the experimental group than for the control group, *t* (81) = −3.2, *p* \< .05. Participants who received the asthma self-management program carry out more asthma management behaviours compared to participants who received the standard asthma care when they experienced asthma attacks (see [Table 3](#tbl3){ref-type="table"}).

4.5. Asthma symptoms {#sec4.5}
--------------------

The difference in median Asthma Control Test (ACT) from T1 to T2 was 1.0 for two groups. The Mann-Whitney *U* indicated there was no significant difference between the two groups regarding the change in the ACT, *U* = 716 (*p* \> .05). These findings indicate that the change in the asthma control test scores from T1 to T2 was not significantly different between groups (see [Table 4](#tbl4){ref-type="table"}).

5. Discussion {#sec5}
=============

The significant effects of the ASMP were found in self-efficacy, outcome-expectancy, and management behaviours, but not on asthma symptoms. The ASMP has taken accounted for adolescents\' developmental stages to further advance the significant results. Previous studies showed that adolescents often denied their disease, non-adhered to asthma management recommendations, as they may worry about medications side effects, felt embarrassed about using an inhaler in front of their peers \[[@bib5],[@bib33],[@bib34]\]. Adolescents could be seen as "not tough", feared to be kept away from their peers, therefore they declined to make their peers aware of their asthma conditions and missing any necessary support \[[@bib18]\]. Furthermore, adolescents would prefer to feel respected, have their own autonomy to make all relevant decisions \[[@bib4]\]. The ASMP was implemented by valuing adolescents' prior asthma knowledge and experience, they were more willing to carry out their own asthma self-care plan. The communications were perceived by the participants to be open-minded, non-judgemental, which led to a trusting relationship. Subsequently convincing patients to take in charge and make good effort of carrying their own asthma self-care plan in better managing plan their asthma symptoms.

The findings demonstrated the benefits of an intervention program guided by the self-efficacy model on the health outcomes for patients with chronic diseases \[[@bib35]\]. The results are consistent with a systematic review recommending of using all self-efficacy strategies to optimise the effectiveness of self-management programs for chronic diseases such as asthma \[[@bib10]\]. This study was based on Bandura\'s self-efficacy model through performance accomplishment, vicarious experience, verbal persuasion, and self-evaluation of physiological and emotional states \[[@bib11]\]. Performance accomplishment is the strongest source of increasing self-efficacy; discussing desires and achievable goals were applied to the ASMP. Mastery on asthma self-management skills and vicarious experience by using role models in the booklet were included. Verbal persuasion further enhancing self-efficacy was performed by a phone call and text messages. Finally, physiological and emotional states were aware by feelings of having asthma flare-up. In contrast, in other studies \[[@bib34],[@bib36]\] where self-management intervention without applying or explicitly illustrating all four sources for enhancing self-efficacy would have less effective. Thus, the findings support the need of integrating four sources of information to increase patients\' self-efficacy to an asthma self-management program for adolescents.

The significant improvements in outcome-expectancy levels have highlighted the importance of positive beliefs in performing asthma self-management prevention and management behaviours. The ASMP helped adolescents with asthma to balance both their needs and effective control of their asthma symptoms. Explaining asthma treatment plans to adolescents\' enhanced adherence and lead to less asthma symptoms \[[@bib35]\]. Furthermore, greater outcome-expectancy improvements may be due to provide an individual discussion at face-to-face sessions about adolescents' peer relationships, hence promoting their willingness to perform asthma preventive behaviours \[[@bib18]\].

The significantly improved asthma prevention and management behaviours is related to people who have high self-confidence and outcome-expectancy levels \[[@bib11]\]. Evidence from previous research supports self-efficacy as the strongest predictor for health promoting behaviours in adolescents \[[@bib35]\]. Previous studies have reported that adolescents with asthma and high levels of self-efficacy had improved asthma adherence, as well as self-confidence in coping with barriers when performing their asthma self-care \[[@bib36]\]. It may be that participants who received the asthma self-management program had a better understanding of the purpose of prevention behaviours and felt confident in carrying out such behaviours. Consequently participants may have then been more willing to perform asthma self-care activities \[[@bib37]\].

Improved asthma management behaviours could be possibly enhanced by in-depth and cumulated discussions. For example, participants in the ASMP were more self-reflecting their own asthma symptoms after relief inhaler usage and asking for help with worsening asthma symptoms. These results were unlike those of previous studies, which found that adolescents with asthma did not treat or manage their breathing problems when they had an asthma attack \[[@bib35],[@bib38]\]. These findings demonstrated that the ASMP made positive progressing of managing asthma flare-ups. Moreover, a written asthma action plan was provided to participants for enabling them to take more achievable steps in managing an asthma flare-up \[[@bib39],[@bib40]\].

The statistical insignificant Asthma Control Test (ACT) scores could be due to participants who were at less severity levels of asthma levels (mild intermittent to moderate). This finding is similar to a study showed more obvious effectiveness on moderate and severe asthma patients \[[@bib41]\]. Another possible rationale could be due to the seasonal factors. Moist and cold weather may have induced more severe asthma symptoms \[[@bib42],[@bib43]\], however, the ASMP was conducted in low humidity summer season in Taiwan. Therefore, a longitudinal study of the ASMP will be needed.

5.1. Limitations {#sec5.1}
----------------

Limitations are identified including generalizability of the results and follow-up time after implementing the ASMP. Given there were no significant findings on asthma symptoms in Chinese adolescents, concerns are raised about the generalizability of this outcome. Data collection with all seasons will provide evidence for long-term effect.

6. Conclusions {#sec6}
==============

This study has addressed gaps in past research of not using a theoretical model to guide the development of an ASMP led to inconsistent results. The features of the ASMP included taking account of a key behaviour measurement of outcome-expectancy, adolescents' developmental characteristics and needs. The positive results demonstrated the effects of the ASMP in asthma self-efficacy, self-management, outcome-expectancy, prevention and management behaviours. The ASMP has also highlighted the great potential benefits of using multifaceted and interactive learning strategies into an educational program.
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ASMPAsthma Self-Management ProgramACTAsthma Control Test

Not applicable.

[^1]: ^NS^ = *non-significant*.

[^2]: *P* \< 0.05.

[^3]: The range of self-efficacy 14-140.

[^4]: The range of prevention behaviour 0-33.

[^5]: The range of management behaviors 0-27.

[^6]: *P* \< 0.05.

[^7]: The range of outcome expectancy 8-80.

[^8]: The range of asthma symptoms 5-25.
